Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
This report aims to provide a comprehensive presentation of the global market for Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Technologies for Delivery of Proteins, Antibodies and Nucleic Acids. This report contains market size and forecasts of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids in global, including the following market information:
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neurological disorders and autoimmune diseases. And apply a variety of new technologies.
We surveyed the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, by Type, 2022 (%)
HEPtune? Technology
Intravail? Technology
RapidMist?
TheraKine Technology
Arestat? Technology
DelSiTech? Silica Matrix
ImSus? Technology
PLEX? Technology
ENHANZE? Technology
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, by Application, 2022 (%)
Delivery of Protein
Delivery of Nucleic Acids
Delivery Antibody
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aphios
Arbutus Biopharma
Camurus
ConjuChem
InnoCore Pharmaceuticals
LATITUDE Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, market overview.
Chapter 2: Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market size in revenue.
Chapter 3: Detailed analysis of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Overall Market Size
2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size: 2022 VS 2030
2.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market
3.2 Top Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies Ranked by Revenue
3.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Companies
3.4 Top 3 and Top 5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies in Global Market, by Revenue in 2022
3.5 Global Companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Type
3.6 Tier 1, Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market
3.6.1 List of Global Tier 1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies
3.6.2 List of Global Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Markets, 2022 & 2030
4.1.2 HEPtune? Technology
4.1.3 Intravail? Technology
4.1.4 RapidMist?
4.1.5 TheraKine Technology
4.1.6 Arestat? Technology
4.1.7 DelSiTech? Silica Matrix
4.1.8 ImSus? Technology
4.1.9 PLEX? Technology
4.1.10 ENHANZE? Technology
4.2 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
4.2.1 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2023
4.2.2 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2024-2030
4.2.3 By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2022 & 2030
5.1.2 Delivery of Protein
5.1.3 Delivery of Nucleic Acids
5.1.4 Delivery Antibody
5.2 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
5.2.1 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2023
5.2.2 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2024-2030
5.2.3 By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2022 & 2030
6.2 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue & Forecasts
6.2.1 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2023
6.2.2 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2024-2030
6.2.3 By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030
6.3.2 US Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.3.3 Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.3.4 Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030
6.4.2 Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.3 France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.4 U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.5 Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.6 Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.7 Nordic Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.4.8 Benelux Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030
6.5.2 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.5.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.5.4 South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.5.5 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.5.6 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030
6.6.2 Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.6.3 Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030
6.7.2 Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.7.3 Israel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.7.4 Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
6.7.5 UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, 2018-2030
7 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies Profiles
7.1 Aphios
7.1.1 Aphios Company Summary
7.1.2 Aphios Business Overview
7.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.1.4 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.1.5 Aphios Key News & Latest Developments
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Company Summary
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.2.4 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.2.5 Arbutus Biopharma Key News & Latest Developments
7.3 Camurus
7.3.1 Camurus Company Summary
7.3.2 Camurus Business Overview
7.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.3.4 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.3.5 Camurus Key News & Latest Developments
7.4 ConjuChem
7.4.1 ConjuChem Company Summary
7.4.2 ConjuChem Business Overview
7.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.4.4 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.4.5 ConjuChem Key News & Latest Developments
7.5 InnoCore Pharmaceuticals
7.5.1 InnoCore Pharmaceuticals Company Summary
7.5.2 InnoCore Pharmaceuticals Business Overview
7.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.5.4 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.5.5 InnoCore Pharmaceuticals Key News & Latest Developments
7.6 LATITUDE Pharmaceuticals
7.6.1 LATITUDE Pharmaceuticals Company Summary
7.6.2 LATITUDE Pharmaceuticals Business Overview
7.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Major Product Offerings
7.6.4 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global Market (2018-2023)
7.6.5 LATITUDE Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Opportunities & Trends in Global Market
Table 2. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers in Global Market
Table 3. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints in Global Market
Table 4. Key Players of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids in Global Market
Table 5. Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Companies, 2018-2023
Table 8. Global Companies Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Type
Table 9. List of Global Tier 1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2024-2030
Table 30. Aphios Company Summary
Table 31. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 32. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 33. Aphios Key News & Latest Developments
Table 34. Arbutus Biopharma Company Summary
Table 35. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 36. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 37. Arbutus Biopharma Key News & Latest Developments
Table 38. Camurus Company Summary
Table 39. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 40. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 41. Camurus Key News & Latest Developments
Table 42. ConjuChem Company Summary
Table 43. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 44. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 45. ConjuChem Key News & Latest Developments
Table 46. InnoCore Pharmaceuticals Company Summary
Table 47. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 48. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 49. InnoCore Pharmaceuticals Key News & Latest Developments
Table 50. LATITUDE Pharmaceuticals Company Summary
Table 51. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Offerings
Table 52. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (US$, Mn) & (2018-2023)
Table 53. LATITUDE Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Segment by Type in 2022
Figure 2. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Segment by Application in 2022
Figure 3. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2022
Figure 8. By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 9. By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 10. By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 12. By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 14. By Region - Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 15. By Country - North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 16. US Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 20. Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 21. France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 28. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 32. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 34. Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share, 2018-2030
Figure 37. Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, (US$, Mn), 2018-2030
Figure 41. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
